Umoja Biopharma (Series B)

Funding Details
Awarder
Inbox
Date Award
June 15, 2021
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$210,000,000

Company Info
Founders
Andrew Scharenberg, M.D.
Company Description
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Market
Immunotherapy
Location
Seattle, WA, USA
Coinvestors
CaaS Capital Management, Casdin Capital, Cormorant Asset Management, DCVC, MPM Capital, Presight Capital, Qiming Venture Partners, RTW Investments, SoftBank Vision Fund 2, Temasek, The Emerson Collective

Links